Clinical Trial Update: Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial of ASM-024 in mild allergic asthma reports safety, tolerability and clinical activity in treated subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ASM-024

Snippet

Sponsor: Asmacure Ltée | Conditions: Mild Allergic Asthma | Phase 2 | Status: COMPLETED